Emerging minimally invasive techniques for treating localized prostate cancer

BJU International

Volumn 96, Issue 9, 2005, Pages 1230-1234

  Ahmed, Shwan ^a   Lindsey, Bronagh ^a   Davies, John ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Cryotherapy; HIFU; Microwave; Photodynamic; Prostate cancer treatment; Radiofrequency

Indexed keywords

AMINOLEVULINIC ACID; ETHYLETIOPURPURIN; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TETRAHYDROXYPHENYL CHLORINE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CRYOSURGERY; CRYOTHERAPY; DRUG SAFETY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; MICROWAVE THERAPY; MINIMALLY INVASIVE SURGERY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOFREQUENCY; RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION; SEXUAL DYSFUNCTION; SHORT SURVEY; STRESS INCONTINENCE; TUMOR LOCALIZATION;

CATHETER ABLATION; CRYOTHERAPY; HUMANS; MALE; MICROWAVES; PHOTOCHEMOTHERAPY; PROSTATIC NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; ULTRASONIC THERAPY;

EID: 28544448335     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05742.x     Document Type: Short Survey

References (41)

1. Bono AV. The global state of prostate cancer: epidemiology and screening in the second millennium. BJU Int 2004; 94 (Suppl. 3): 1-2
2. Beerlage HP, Thüroff S, Madersbacher S et al. Current status of minimally invasive treatment options for localised prostate carcinoma, Eur Urol 2000; 37: 2-13
3. Zelefsky MJ, Wallner KE, Ling CC et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999; 17: 517-22
4. Ahmed S, Lindsey B, Davies J. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy. Prostate Cancer Prostatic Dis 2005; 8: 31-5
5. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966; 3: 372-8
6. Onik G, Cohen J, Reyes G, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72: 1291-9
7. Theodorescu D. Cancer cryotherapy. evolution and biology. Rev Urol 2004; 6 (Suppl. 4): S9-S19
8. Saliken JC, Donnelly BJ, Rewcastle JC. The evolution and state of modern technology for prostate cryosurgery. Urology 2002; 60 (Suppl. 2A): 26-33
9. Wong W, Chinn DO, Chinn M, Chinn J, Tom WL, Tom WL. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 1997; 79: 963-74
10. Derrick FC, Britton JJ, Carter WC et al. Cryoablation of the prostate for localised prostate cancer. 8 year experience with 215 cases. J Urol 2003; 169: 459
11. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2003; 60 (Suppl. 2A): 3-11
12. Katz AE. Targeted cryosurgical ablation of the prostate (TCAP) for patients failing radiation: 6-year observations. J Urol 2004; 171: 272
13. Bahn DK, Lee F, Silverman P et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003; 2: 111-4
14. Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004; 93: 14-8
15. Ahmed S, Davies J. Managing the complications of prostate cryosurgery. BJU Int 2005; 95: 480-1
16. Rees J, Patel B, MacDonagh R, Persad R. Cryosurgery for prostate cancer. BJU Int 2004; 93: 710-4
17. Colombel M, Poissonnoer L, Gelet A. High intensity focused ultrasound for localised prostate cancer. Eur Urol 2004; 44 (Suppl): 21-4
18. Uchida T, Sanghvi NT, Gardner TA et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2NOMO localised prostate cancer: a preliminary report. Urology 2002; 159: 394-9
19. Thüroff S, Chaussy C, Vallancien G et al. High-intensity focused ultrasound and localised prostate cancer: efficacy results from the European multicentric study. J Endourol 2003; 17: 673-7
20. Poissonnier L, Gelet A, Chapelon J et al. Prostate cancer control with transrectal HIFU in 230 patients: five-year results. Eur Urol Suppl 2005; 4: 44
21. Poissonnier L, Gelet A, Chapelon JY et al. Local recurrence of prostate cancer after external beam radiation: early experience of salvage therapy using high intensity focused ultrasound. Eur Urol Suppl 2004; 4: 79
22. Chaussy C, Thüroff S. The status of high-intensity focused ultrasound in the treatment of localised prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248-52
23. Chakrabarti P, Orihuela E, Egger N et al. Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: implication for photodynamic therapy of prostate cancer. Prostate 1998; 36: 211-8
24. Diamond I, Granelli SG, McDonagh AF, Nielsen S, Wilson CB, Jaenicke R. Photodynamic therapy of malignant tumors. Lancet 1972; 2: 1175-7
25. Camps JL Jr, Powers SK, Beckman WC Jr, Brown JT, Weissman RM. Photodynamic therapy of prostate cancer: an in vitro study. J Urol 1985; 134: 1222-6
26. Windahl T, Anderson SO, Lofgren L Photodynamic therapy of localised prostatic cancer. Lancet 1990; 336: 1139
27. Zaak D, Sroka R, Stocker S et al. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the Dunning rat tumor model. Urol Int 2004; 72: 196-202
28. Selman SH, Keck RW, Hampton JA. Transperineal photodynamic ablation of the canine prostate. J Urol 1996; 156: 258-60
29. Nathan TR, Whitelaw DE, Chang SC et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 2002; 168: 1427-32
30. Chen Q, Huang Z, Luck D et al. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photocnem Photobiol 2002; 76: 438-45
31. Gertner MR, Bogaards A, Weersink RA et al. Initial results of a phase I/II trial of WST09-mediated photodynamic therapy (WST09-PDT) for recurrent prostate cancer following failed external beam radiation therapy (EBRT). Eur Urol Suppl 2004; 3: 212
32. Sherar MD, Gertner MR, Yue CKK et al. Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. J Urol 2001; 166: 1707-14
33. Yerushalmi A, Fishelovitz Y, Singer D et al. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985; 133: 873-6
34. Yerushalmi A, Shpirer Z, Hod I, Gottesfeld F, Bass DD. Normal tissue response to localized deep microwave hyperthermia in rabbit's prostate: a preclinical study. Int J Rad Oncol Biol Phys 1983; 9: 77-82
35. Baert L, Ameye F, Pike MC, Willemen P, Astrahan MA, Petrovich Z. Transurethral hyperthermia for benign prostatic hyperplasia patients with retention. J Urol 1992; 147: 1558-61
36. Trachtenberg J, Goldfarb B, Bartkiw T. Interstitial microwave thermotherapy for residual prostate cancer after radiation therapy. J Urol 1996; 155: 646A
37. McCann C, Kumaradas JC, Gertner MR, Davidson SR, Dolan AM, Sherar MD. Feasibility of salvage interstitial microwave thermal therapy for prostate carcinoma following failed brachytherapy: studies in a tissue equivalent phantom. Phys Med Biol 2003; 48: 1041-52
38. Zlotta AR, Djavan B, Matos C et al. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol 1998; 81: 265-75
39. Schulman CC, Zlotta AR. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology 1995; 45: 28-33
40. Selli C, Scott A, Garbagnati F et al. Transurethral radiofrequency thermal ablation of prostatic tissue: a feasibility study in humans. Urology 2001; 57: 78-82
41. Djavan B, Zlotta AR, Susani M et al. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. Urology 1997; 50: 986-93